Genetic variability of inflammation and oxidative stress genes does not play a major role in the occurrence of adverse events of dopaminergic treatment in Parkinson's disease.
Journal of neuroinflammation 2019 Feb 16 (1): 50.
Redenšek Sara, Flisar Dušan, Kojovic Maja, Kramberger Milica Gregoric, Georgiev Dejan, Pirtošek Zvezdan, Trošt Maja, Dolžan Vi
- Page last reviewed:Jul 30, 2019
- Page last updated:Aug 22, 2019
- Content source: